Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Yamanouchi reports squalene synthase inhibitors

Aug. 9, 1996

Alfa Wasserman reveals antioxidant hypolipidemic compounds

Aug. 9, 1996

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

Duphar reports Vitamin D compounds with multiple therapeutic activity

Aug. 9, 1996

Comparative study results of Systen and Menorest

July 26, 1996

Prostaglandin E1 regimen shows positive results for male erectile dysfunction

July 26, 1996

ALT-766: New AGE cross-link breaker from Alteon

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

Ibex licenses technology from Centre for Applied Microbiology and Research

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...